To demonstrate this, we included PRO-seq libraries from H9 human cutaneous T-cell lymphoma cell lines treated with either DMSO (n=3) or an HDAC inhibitor (n=3). Here, HDAC9 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.